Parameters | Group I | Group II | Test of Sig. | P | ||
CC (n = 17) | CG + GG (n = 8) | CC (n = 16) | CG (n = 9) | |||
Age (years) | 41.82 ± 12.17 | 47.88 ± 15.90 | 50.25 ± 17.92 | 45.78 ± 15.1 | F = 0.871 | 0.463 |
Sex Male Female |
8 (47.1%) 9 (52.9%) |
5 (62.5%) 3 (37.5%) |
6 (37.5%) 10 (32.5%) |
5 (55.6%) 4 (44.4%) | χ2 = 1.645 | 0.709 |
Spleen size (cm) | 20.28 ± 4.08 | 22.13 ± 4.49 | 24.03 ± 3.20 | 26.89 ± 3.72 | F = 6.437 | 0.001* |
Sokal score Low Intermediate High |
4 (23.5%) 8 (47.1%) 5 (29.4) |
0 2 (25%) 6 (75%) |
0 4 (26.7%) 11 (73.3%) |
0 1 (11.1%) 8 (88.9%) | χ2 = 11.954 | 0.026* |
Hemoglobin (g/dl) | 10.61 ± 1.46 | 9.74 ± 2.56 | 10.28 ± 2.04 | 9.93 ± 2.18 | F = 0.440 | 0.726 |
Platelets (×109/L) | 351.8 ± 177.2 | 384.3 ± 226.5 | 372.3 ± 264.5 | 373.6 ± 233.4 | H = 0.116 | 0.990 |
WBCs (×109/L) | 187.6 ± 163.9 | 249.6 ± 178.1 | 114.1 ± 109.4 | 155.2 ± 125.6 | H = 4.676 | 0.197 |
BCR-ABL1 at diagnosis (%) | 69.96 ± 25.14 | 73.29 ± 32.12 | 72.12 ± 21.16 | 77.0 ± 26.63 | H = 0.484 | 0.902 |
EMR** | ≤10% | >10% | χ2 = 0.089 | 0.765 |